Effect of liraglutide on inflammatory response of peripheral blood mononuclear cells (PBMCs) in subjects at risk of type 2 diabetes

2022/45/N/NZ7/03393

Keywords

Descriptors

  • NZ7_012: Prewencja chorób człowieka

Panel

NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution

Uniwersytet Medyczny w Białymstoku

Voivodeship: podlaskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

Marta Dobrzycka

Number of co-investigators in the project: 3

Call

PRELUDIUM 21 – announced on 2022-03-28

Amount awarded
209 230 PLN
Project start date
2023-02-01
Project end date
2027-01-31
Project duration
48 months (the same as in the proposal)
Project status
Pending project

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

« New search

Graphic design and implementation: Jakub Piotrowski